ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $932,820 | -18.6% | 85,189 | -1.6% | 0.01% | -16.7% |
| Q2 2023 | $1,146,558 | -26.1% | 86,598 | -24.1% | 0.01% | -45.5% |
| Q1 2023 | $1,552,221 | -22.6% | 114,050 | +11.1% | 0.01% | -35.3% |
| Q4 2022 | $2,005,067 | -16.5% | 102,666 | -18.6% | 0.02% | -34.6% |
| Q3 2022 | $2,402,000 | +17.3% | 126,101 | +26.9% | 0.03% | +36.8% |
| Q2 2022 | $2,047,000 | -34.6% | 99,368 | +2.1% | 0.02% | 0.0% |
| Q1 2022 | $3,131,000 | +66.8% | 97,301 | +141.3% | 0.02% | +90.0% |
| Q4 2021 | $1,877,000 | +101.8% | 40,316 | +48.1% | 0.01% | +66.7% |
| Q1 2021 | $930,000 | – | 27,221 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |